Form D · Hedge Fund
Sofinnova BioEquities Enhanced Master Fund, LP
Menlo Park, CA · CIK 0001949475
Offering snapshot reported Oct 10, 2025 · SEC filing
- Reported sold
- $41.5M Indefinite offering
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 3, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$35,675,289 → $41,545,600
- Reported investors17 → 25
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2025 | Amendment | $41,545,600 | $5,870,311vs Oct 11, 2024 | 25 | SEC filing |
| Oct 11, 2024 | Amendment | $35,675,289 | $26,699,091vs Oct 13, 2023 | 17 | SEC filing |
| Oct 13, 2023 | Amendment | $8,976,198 | $6,996,003vs Oct 13, 2022 | 11 | SEC filing |
| Oct 13, 2022 | Initial | $1,980,195 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-461670
Source: Form D, filed Oct 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.
Matched by reported Form D file number
SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LP
Investment adviser: SOFINNOVA INVESTMENTS, INC.
- Gross asset value
- $1.19B
- Beneficial owners
- 28
- ADV minimum commitment
- $3M
Reported in Form ADV on Mar 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
See filing for more → Showing the first 6 providers by role and name. IAPD may show a newer filing.
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG, LLP
PCAOB 185
EQUINITI TRUST COMPANY, LLC
LEI 213800YI5RL9BRL4V892
GOLDMAN SACHS & CO. LLC
SEC 8-129
Fund asset history · 4 annual observations
Scroll to see all columns →
| Fiscal year | Gross assets | Beneficial owners | ADV filed |
|---|---|---|---|
| 2022 | $627,080,291 | 12 | Mar 29, 2023 |
| 2023 | $765,846,681 | 18 | Mar 15, 2024 |
| 2024 | $834,290,304 | 27 | Mar 20, 2025 |
| 2025 | $1,194,871,723 | 28 | Mar 27, 2026 |
Filing source
Form ADV 2075659 · Mar 27, 2026 · Schedule D 7.B.(1), fund 805-6350579768
Reported by SOFINNOVA INVESTMENTS, INC. (CRD 160297).
Annual Updating Amendment for Registered Adviser · fiscal year 2025.
Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sofinnova Bio Equities Gp Llc | Executive, Promoter |
| Sofinnova Investments, Inc. | Executive, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Menlo Park, CA, 94025
Phone: 650-681-8482